Camm AJ, Atar D (2021)
Use of Non-vitamin K Antagonist Oral Anticoagulants for Stroke Prevention across the Stroke Spectrum: Progress and Prospects
Thromb Haemost (in press)
DOI 10.1055/s-0040-1721665, PubMed 33412613

Agewall S (2021)
Atrial fibrillation in registries
Eur Heart J Cardiovasc Pharmacother, 7 (1), 1-2
DOI 10.1093/ehjcvp/pvaa142, PubMed 33367509

De Caterina R, Patti G, Westerbergh J, Horowitz J, Ezekowitz JA, Lewis BS, Lopes RD, McMurray JJV, Atar D, Bahit MC, Keltai M, López-Sendón JL, Ruzyllo W, Granger CB, Alexander JH, Wallentin L (2020)
Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial
Eur Heart J Cardiovasc Pharmacother (in press)
DOI 10.1093/ehjcvp/pvaa140, PubMed 33367487